Observational studyCardiovascular diabetology2016

Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up.

Takashi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.